The prescription sale of testosterone is a big business – nationally reaching $1.6 billion in 2011. The percentage of men 40 and over being treated for what has been termed “Low T Syndrome” has tripled from 2001 to 2011. Recent studies, though, have suggested that “Low T Syndrome” treatment offers no proven benefits for healthy men. Rather, it seems that “Low T Syndrome” is an invention of pharmaceutical companies designed to sell treatment products.
The risks of using testosterone seem to far outweigh the proposed benefits. Medical research has advised that men using testosterone may be at a significantly greater risk for a myriad of health issues, including cardiac events such as stroke, pulmonary embolism and death. (Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Prescription In Men, published January 2014; Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stoke in Men With Low Testosterone Levels, published November 2013). The FDA announced on January 31, 2014 that it will commence investigation on the risk of stroke, heart attack and death with FDA approved testosterone products based on the recent medical research.
“Low T Syndrome” treatment products come in a variety of forms, including topical gels, transdermal patches, bucal systems and injections. There are more than 25 of these “Low T Syndrome” treatment products on the market, but the most common are: Androgel, Axiron Testopel, Androderm, Fortesta, Halotestin, Androxy, Testim, and Striant.
If you or a loved one has suffered a complication from the treatment of “Low T Syndrome” please contact an attorney at Nager, Romaine & Schneiberg Co., L.P.A in Cleveland, Ohio. We would be happy to assist you regarding your testosterone injury case any where in the United States. Please contact us today at 216-289-4740 or Toll Free from Ohio at (855) Got-Hurt.